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Rescue of a Porcine Anellovirus (Torque Teno Sus Virus 2) from
Cloned Genomic DNA in Pigs
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Michael B. Roof,b and Xiang-Jin Menga
Department of Biomedical Sciences and Pathobiology, College of Veterinary Medicine, Virginia Polytechnic Institute and State University (Virginia Tech), Blacksburg,
Virginia, USAa; Boehringer Ingelheim Vetmedica, Inc., Ames, Iowa, USAb; Department of Veterinary Diagnostic and Animal Medicine, College of Veterinary Medicine, Iowa
State University, Ames, Iowa, USAc; and BioScreen European Veterinary Disease Management Center GmbH, Münster, Germanyd
Anelloviruses are a group of single-stranded circular DNA viruses infecting humans and other animal species. Animal models
combined with reverse genetic systems of anellovirus have not been developed.We report here the construction and initial char-
acterization of full-length DNA clones of a porcine anellovirus, torque teno sus virus 2 (TTSuV2), in vitro and in vivo. We first
demonstrated that five cell lines, including PK-15 cells, are free of TTSuV1 or TTSuV2 contamination, as determined by a real-
time PCR and an immunofluorescence assay (IFA) using anti-TTSuV antibodies. Recombinant plasmids harboring monomeric
or tandem-dimerized genomic DNA of TTSuV2 from the United States and Germany were constructed. Circular TTSuV2
genomic DNAwith or without introduced genetic markers and tandem-dimerized TTSuV2 plasmids were transfected into
PK-15 cells, respectively. Splicing of viral mRNAs was identified in transfected cells. Expression of TTSuV2-specific open reading
frame 1 (ORF1) in cell nuclei, especially in nucleoli, was detected by IFA. However, evidence of productive TTSuV2 infection was
not observed in 12 different cell lines transfected with the TTSuV2 DNA clones. Transfection with circular DNA from a TTSuV2
deletion mutant did not produce ORF1 protein, suggesting that the observed ORF1 expression is driven by TTSuV2 DNA repli-
cation in cells. Pigs inoculated with either the tandem-dimerized clones or circular genomic DNA of U.S. TTSuV2 developed
viremia, and the introduced genetic markers were retained in viral DNA recovered from the sera of infected pigs. The availability
of an infectious DNA clone of TTSuV2 will facilitate future study of porcine anellovirus pathogenesis and biology.
Anelloviruses are small, single-stranded, circular DNA virusesthat infect a wide range of animal species, from humans to
domestic animals, including pigs (13, 34). Most recently, all hu-
man and other animal anelloviruses have been assigned to a newly
established family, Anelloviridae, that includes nine genera (3).
Human anelloviruses include torque teno virus (TTV), torque
teno minivirus (TTMV), and torque teno midivirus (TTMDV),
which belong to three different genera. Human TTV, TTMV, and
TTMDV are nonenveloped spherical viruses with DNA genomes
3.6 to 3.9, 2.8 to 2.9, and 3.2 kb long, respectively (33). These three
groups of human anelloviruses show a high degree of genetic di-
versity, and a high prevalence of infections with TTV, TTMV, and
TTMDV in human populations has been documented worldwide
(32, 33).On the other hand, porcine anellovirus or torque teno sus
virus (TTSuV) is assigned to a new genus, Iotatorquevirus, com-
prising two species (TTSuV1 and TTSuV2), each also character-
ized by high genetic diversitywith a genomic size of approximately
2.8 kb (16, 31). TTSuV1 and TTSuV2 are highly prevalent in pig
populations in many countries (9, 20, 28).
Human and porcine anelloviruses have the same genomic
structure, which consists of at least four presumed open reading
frames (ORFs),ORF1,ORF2,ORF1/1, andORF2/2, aswell as a short
stretchwithhighGCcontent in theuntranslated region (UTR) (5, 16,
36, 38). The transcription pattern and related translational products
ofhumanTTVgenogroup1havebeenexperimentallydeterminedby
using two full-length TTVDNA clones (5, 30, 38). It was shown that
the human TTV genome expresses three or more spliced mRNAs
encoding at least six proteins, ORF1, ORF2, ORF1/1, ORF2/2,
ORF1/2, andORF2/3(5,30).The transcriptional analysis andprotein
expression profile using cloned full-length genomic DNA have not
been reported for TTSuV. TheORF1 of TTSuV is believed to encode
a viral capsid and replication-associated protein (5, 16, 36). IgG anti-
bodies against ORF1 of TTV and TTSuV have been detected in hu-
man and pig sera, respectively (15, 17, 37).
The pathogenic potential of anellovirus is still controversial.
Currently, human TTV is not considered to be directly associated
with a particular disease, although recent studies suggested that
TTV may serve as an immunological trigger of multiple sclerosis
(26). Similarly, whether TTSuV is associated with a swine disease
is still debatable. TTSuV1 was shown to partially contribute to the
experimental induction of porcine dermatitis and nephropathy
syndrome and postweaning multisystemic wasting syndrome
(PMWS or porcine circovirus [PCV]-associated disease, PCVAD)
in a gnotobiotic pig model (6, 21). PMWS-affected pigs in Spain
had a higher prevalence and greater loads of TTSuV2 than did
non-PMWS-affected pigs (1, 20). Moreover, a significantly lower
level of anti-TTSuV2 antibodywas found in PCVAD-affected pigs
than in non-PCVAD-affected pigs (15). However, results from
other studies did not support a direct association of TTSuV1 or
TTSuV2with PCVADor an association of type 2 PCV (PCV2) and
TTSuV with porcine reproductive failures (10, 23, 39; Y. W.
Huang et al., submitted for publication).
Due to the lack of a cell culture system to propagate anellovi-
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ruses, little is known regarding the molecular biology and patho-
genesis of anelloviruses. In order to definitively characterize dis-
eases associated with anellovirus infection, an appropriate animal
model is needed. Since infections with multiple different geno-
types or subtypes of humanTTVorTTSuVare common events (9,
16, 32), a biologically pure and isolated form of a specific anello-
virus generated from a full-length infectious DNA clone is also
required for a study of the pathology due to a single phenotype.
Although infectious DNA clones of human TTV in cultured cells
have been reported (5, 18, 24), it is important to construct an
infectious TTSuV DNA clone so that TTSuV can be used as a
useful model to study the replication and transcription mecha-
nisms and to dissect the structural and functional relationships of
anellovirus genes. More importantly, the availability of a TTSuV
infectious DNA clone will afford us an opportunity to use the pig
as a model system to study the replication and pathogenesis of
TTSuV or even human TTV.
In the present study, we describe the construction and initial
characterization of full-lengthDNA clones of TTSuV2 in vitro and
in vivo. We provide, for the first time, definite evidence of splicing
of TTSuV2 mRNA and expression of the putative ORF1 capsid
protein by transfection of the TTSuV2 full-length DNA clones in
cultured cells. Furthermore, rescue of TTSuV2 containing the in-
troduced genetic markers in pigs was confirmed by sequencing of
viral DNA obtained from pigs experimentally inoculated with the
circular TTSuV2 genomic DNA.
MATERIALS AND METHODS
Cell lines and cell cultures. A total of 12 continuous cell lines were used in
this study.PCV1-freeporcinekidneyepithelial cell linePK-15 (8), swine testis
cell line ST (ATCCCRL-1746, passage 6), baby hamster kidney fibroblast cell
line BHK-21 (ATCC CCL-10, passage 62), and an African green monkey
kidney epithelial Vero cell line (ATCCCCL-81, passage 95) were each grown
in modified Eagle’s medium supplemented with 10% fetal bovine serum
(FBS) and antibiotics. Porcinemonocytic cell line 3D4/31 (ATCCCRL-2844,
passage 8), porcine small intestinal epithelial cell line IPEC-J2 (a gift from
Anthony Blikslager at North Carolina State University, Raleigh, NC) (40),
and hamster ovary cell line CHO-K1 (ATCCCCL-61, passage 12) were each
cultured in Dulbecco’s modified Eagle’s medium (DMEM) and nutrient
mixture F-12 (Ham) (1:1)withGlutaMAX-I (Invitrogen,Carlsbad,CA) sup-
plementedwith 5%FBS and antibiotics.Monkey kidney cell line subclone
MARC-145 (passage 42) derived from MA-104 (ATCC CRL-2378),
human cervical cancer cell line HeLa (ATCC CCL-2, passage 10), and
human hepatocellular carcinoma cell lines Huh-7 (subclone 10-3; a
gift from Suzanne U. Emerson at NIAID, NIH) (7) and HepG2 (ATCC
CRL-10741, passage 7) were each grown in DMEM supplemented with
10% FBS and antibiotics. Human 293 cell line 293TT, engineered to
stably express high levels of simian virus 40 (SV40) large T antigen (a
gift from John T. Schiller, Laboratory of Cellular Oncology, National
Cancer Institute, Bethesda, MD) (4), was cultured in DMEM-10 me-
dium (DMEM with 10% inactivated FBS, 1% nonessential amino ac-
ids, and 1% GlutaMAX-I) supplemented with 400 g/ml hygromycin
B and antibiotics. All cells were grown at 37°C with 5% CO2.
Analysis of TTSuV1 or TTSuV2 contamination in cultured cells by
real-time quantitative PCR (qPCR). To ensure that the swine-derived
cell lines used in this study were free of TTSuV contamination, five cell
lines, PCV1-free PK-15, 3D4/31, IPEC/J2, BHK-21, andMARC-145, were
tested for TTSuV1 or TTSuV2 DNA by using two singleplex SYBR green-
based real-time qPCR assays (14). Briefly, total DNA was extracted from
each cell line using the QIAampDNAminikit (Qiagen) and subsequently
subjected to TTSuV1 or TTSuV2 qPCR detection in a 25-l PCR system
using the SensiMix SYBR & Fluorescein kit (Quantace Ltd.) as described
previously (14). A TTSuV1 or TTSuV2 standard template and a porcine
serum sample from a commercial company used in cell culture, which is
supposed to be OIE (TheWorld Organization for Animal Health) disease
free, were included as controls.We also tested if the swine-derived trypsin
and FBS products used for cell cultures were contaminated with TTSuVs.
Two trypsin products from twodifferentmanufacturers and an FBS prod-
uct were tested, including one trypsin product that was used for passaging
of the cell lines. The trypsin was heat inactivated at 65°C for 2 h before
DNA extraction. All samples were run in duplicate on the same plate.
Generation of rabbit anti-TTSuV2ORF1 antiserum.We have previ-
ously expressed and purified a recombinant truncated ORF1 protein of
TTSuV2 (PTTV2c-VA strain) (15). The purified protein products were
used to immunize two New Zealand White rabbits as a custom antibody
production service at Rockland Immunochemicals (Gilbertsville, PA). Se-
rum samples from both rabbits were collected before immunization (pre-
bleed) and at 45 days postimmunization. The specificity of the TTSuV2
ORF1 antiserum was demonstrated by Western blot analysis using the
TTSuV2 ORF1 antigen and the bacterial control (cell lysis product from
bacteria harboring the empty expression vector), as well as experiments in
which PK-15 cells were transfected (see below) with the TTSuV2 ORF1
expression construct and two empty vectors, pTriEx1.1-Neo and pSC-B-
amp/kan (data not shown).
Construction of full-length genomic DNA clones of TTSuV2. Two
PCR fragments (E andF) covering the full-length genomeof theU.S. strainof
TTSuV2 isolate PTTV2c-VA (GenBank accession no. GU456386) were re-
amplified from the constructs reported previously (16), which were subse-
quently assembled intoa full-lengthgenomicDNAbyoverlappingPCRusing
the Herculase II Fusion DNA Polymerase (Stratagene) in the vector pSC-B-
amp/kan (Stratagene). Themonomeric TTSuV2DNA fragment was flanked
by a BamHI restriction site at both ends. The resulting construct was desig-
nated pSC-PTTV2c (Fig. 1A). The full-length PTTV2c genome was excised
from clone pSC-PTTV2c by BamHI digestion, purified, and ligated head to
tail to form concatemers. Two-copy concatemers were cloned into the
BamHI-predigested pSC-B-amp/kan vector to produce a tandem-dimerized
TTSuV2 DNA clone, pSC-2PTTV2c-RR (Fig. 1B). Similarly, two plasmids
harboringmonomeric and tandem-dimerized TTSuV2 genomic DNA from
GermanTTSuV2 isolateTTV2-#471942(GenBankaccessionno.GU188046)
(9) were constructed with the EcoRV site on the same vector backbone, re-
spectively.ThemonomericTTSuV2DNAfragmentwasflankedbyanEcoRV
restriction site at both ends (Fig. 1C and D). Since the TTV2-#471942 strain
was classified intoTTSuV2subtype2b togetherwithU.S. isolatePTTV2b-VA
based upon phylogenetic analysis (data not shown), we designated these two
clones pSC-TTV2-#471942 (Fig. 1C) and pSC-2PTTV2b-RR (Fig. 1D), re-
spectively.
Introduction of genetic markers into the two TTSuV2 monomeric
DNA clones and construction of a TTSuV2 deletion mutant. An HpaI
restriction enzyme site was engineered into the putative spliced region
(intron) of the TTSuV2 genome in clone pSC-TTV2-#471942 for the
introduction of a geneticmarker to discriminate between the cloned virus
and the potential indigenous viruses in the subsequent animal study. To
create the unique HpaI site (GTTAAC; mutations are underlined), three
point mutations, C to T, C to A, and T to A at nucleotide positions 1817,
1819, and 1820, corresponding to the TTV2-#471942 genome, were gen-
erated by a fusion PCR technique using two pairs of primers containing
the desired mutations. The fusion PCR product was used to replace the
corresponding region in clone pSC-TTV2-#471942 by using the KpnI
cloning sites at both ends. The mutations were located in the putative
intron of the TTV2-#471942 genome and did not change the putative
ORF1 capsid amino acid sequence. The resulting full-length DNA clone
was named pSC-TTV2-EU (Fig. 1E). Using the same strategy, two unique
restriction sites, PstI (CTGCAG) and MfeI (CAATTG), were introduced
into the putative intron of the PTTV2c-VA genome in the pSC-PTTV2c
clone (Fig. 1F). The new clone, designed pSC-TTV2-US, contained three
silent mutations at nucleotide positions 1613 (A to T), 1784 (T to C), and
1787 (C to T), corresponding to the PTTV2c-VA genome. Amutant clone
pSC-TTV2-AA, with a 104-bp deletion (nucleotide positions 332 to
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437) from the putative TATAbox to theORF1/ORF2 start codon on clone
pSC-TTV2-US, was also generated by removing the short deletion frag-
ment by double digestion with the AccI and ApaI enzymes, followed by
the formation of two blunt ends with the Klenow enzyme and self-ligation
(Fig. 1G). All mutagenesis was confirmed by DNA sequencing.
In vitro transfection of TTSuV DNA clones. PCV1-free PK-15 cells
were seeded at 2  105 per well of a six-well plate and grown until 60 to
70% confluence before transfection. Two-microgram samples of tandem-
dimerized clones pSC-2PTTV2b-RR and pSC-2PTTV2c-RR and vectors
pTriEx1.1-Neo and pSC-B-amp/kan were directly transfected into the
cells, respectively, using Lipofectamine LTX (Invitrogen) according to the
manufacturer’s protocol. For monomeric clones pSC-PTTV2c, pSC-
TTV2-#471942, pSC-TTV2-EU, pSC-TTV2-US, and pSC-TTV2-AA,
the respective genomic fragment was excised with the BamHI or EcoRV
enzyme, gel purified, and religated with T4 DNA ligase overnight. The
ligationmixtures (2g) were used for transfection using Lipofectamine
LTX, respectively. Cells were cultured for 3 to 5 days and then subjected to
an immunofluorescence assay (IFA) to detect the expression of ORF1.
Alternatively, transfected cells were passaged into new six-well plates and
cultured for 3 days before detection of ORF1 expression by IFA. Trans-
fection of the other 11 cell lines and IFA detection were done similarly.
IFA. Transfected or passaged cells on six-well plates were washed two
times with phosphate-buffered saline (PBS) and fixed with acetone. Five
hundred microliters of anti-TTSuV2 ORF1 antiserum at a 1:500 dilution
in PBS was added to the cells for each well and incubated for 1 h at room
temperature. Cells were washed three times with PBS, and 500 l Texas
Red- or Alexa Fluor 488-conjugated goat anti-rabbit IgG (Invitrogen) at a
1:300 dilution was subsequently added. After incubation for 1 h at room
FIG 1 Schematic diagrams of TTSuV2 constructs containing full-length TTSuV2 genomic DNA. (A) pSC-PTTV2c (from U.S. TTSuV2 isolate PTTV2c-VA
[GenBank accession no. GU456386]). (B) pSC-2PTTV2c-RR (tandem-dimerized PTTV2c-VA genomes). (C) pSC-TTV2-#471942 (from German TTSuV2
isolate TTV2-#471942 [GenBank accession no. GU188046]). (D) pSC-2PTTV2b-RR (tandem-dimerized TTV2-#471942 genomes). (E) pSC-TTV2-EU (derived
frompSC-TTV2-#471942). AnHpaI site was introduced into this clone as a silent geneticmarker. (F) pSC-TTV2-US (derived frompSC-PTTV2c). PstI andMfeI
sites were introduced into this clone as silent genetic markers. (G) pSC-TTV2-AA. A 104-bp deletionmutation was introduced between the AccI and ApaI sites
ranging from the putative TATA box to theORF1 start codon in clone pSC-TTV2-US. The restriction enzyme (BamHI or EcoRV) used for plasmid construction
is shown. The nucleotide positions of the restriction enzymes corresponding to the genomic sequences, the termini of the virus genome, ORF1, and ORF2 are
labeled. The plasmid backbone used for cloning was the pSC-B-amp/kan vector (indicated by black). Gray arrows indicate the TTSuV2 genomic copies.
Huang et al.
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temperature, the cells were washed with PBS, stained with 500 l 4=,6-
diamidino-2-phenylindole (DAPI; KPL, Inc.) at a 1:1,000 dilution, and
visualized under a fluorescence microscope.
Reverse transcription (RT)-PCR. Total RNA was extracted from
PCV1-free PK-15 cells transfected with circular TTSuV2 DNA or the
cloning vector pSC-B-amp/kan using the RNeasy minikit (Qiagen), fol-
lowed by RNase-free DNase I treatment. The cDNA synthesis was per-
formed using SuperScript II reverse transcriptase (Invitrogen) with
oligo(dT) as the reverse primer. PCR was performed in a 50-l reaction
mixture with the Advantage 2 PCR kit (Clontech) using primers TTV2-
448F (5=-GAAGAAAGATGGCTGACGGTAGCGTACT-3=) and TTV2-
2316R (5=-AGGTGCTTGAGGAGTCGTCGCTTG-3=). The PCR prod-
ucts were gel purified, cloned into the pCR2.1 vector (Invitrogen) by the
TA cloning strategy, and sequenced.
In vivo transfection of colostrum-deprived (CD) pigs with tandem-
dimerized TTSuV2 clones. It has been previously demonstrated that the
infectivity of infectious DNA clones of viruses with circular genomes can
be tested by direct inoculation of dimerized full-length genomicDNA into
animals (8). Therefore, in this study, a pilot animal study was initially
conducted to determine the infectivity of tandem-dimerized TTSuV2
clones pSC-2TTV2c-RR and pSC-2TTV2b-RR. Briefly, six 26-day-old
CD pigs that were seronegative and negative for TTSuV1 and TTSuV2
viral DNA were assigned to three groups of two each. Each group of pigs
was housed separately andmaintained under conditions thatmet all of the
requirements of the Institutional Animal Care and Use Committee. The
pigs in each groupwere injected by using a combination of intralymphoid
(superficial inguinal lymph nodes) and intramuscular routes with the
plasmidDNAof the full-lengthTTSuV2 clones. The twopigs (no. 1 and 2)
in group 1 were each given 1 ml of PBS buffer and used as the negative
control. The two pigs (no. 3 and 4) in group 2 were each injected with 200
g of pSC-2TTV2c-RR plasmid DNA, and the two pigs (no. 5 and 6) in
group 3 were each inoculated with 200 g of the pSC-2TTV2b-RR clone.
Pigs weremonitored daily for evidence of TTSuV2 infection for a total
of 44 days. All pigs were necropsied at 44 days postinoculation (dpi).
Serum samples were collected from all of the pigs prior to inoculation and
weekly thereafter until termination of the study. The samples were tested
for the presence of TTSuV DNA and viral loads were quantified by a
singleplex TTSuV2-specific real-time qPCR (14). Brain, lung, lymph
node, liver, kidney, thymus, spleen, small intestine, large intestine, heart,
tonsil, and bone marrow tissue samples were collected during necropsies
and processed formicroscopic examination. The tissueswere examined in
a fashion blinded to the treatment status of the pigs and given a subjective
score for severity of tissue lesions ranging from 0 (normal) to 3 (severe)
(8, 11).
In vivo transfection of cesarean-derived CD (CD/CD) pigs with the
circularized TTSuV2 genomic DNA containing genetic markers. To
further verify the results of the initial pilot pig study, we introduced trac-
table genetic markers into the full-length DNA clones and conducted
another CD/CD pig study. Approximately 600 g of circular or concate-
merized TTSuV2 genomic DNA derived from clone pSC-TTV2-EU or
pSC-TTV2-US was generated by ligation of the linearized TTSuV2
genomic DNA. To determine the infectivity of the full-length DNA
clones, we inoculated each of four 40-day-old CD/CD pigs (no. 129, 135,
139, and 140 in group 1) with 150 g of concatemerized TTV2-EU DNA
by a combination of the intralymphoid and intramuscular routes. An-
other four CD/CD pigs (no. 133, 137, 138, and 141) in group 2, which
were housed in a separate room, were each similarly inoculated with 150
g of concatemerized TTV2-US DNA. The remaining four CD/CD pigs
(no. 127, 132, 136, and 142) in group 3 were each injected with 1.5 ml of
PBS buffer and served as negative controls. All pigs were monitored for
evidence of TTSuV2 infection for 35 days and then necropsied. Total
DNA was extracted without DNase I pretreatment from all samples and
withDNase I pretreatment from selected samples. Viremia was tested by a
TTSuV2 real-time qPCR (14). A TTSuV2 genomic region of 620 bp con-
taining the engineered genetic markers in TTV2-EU or TTV2-US was
amplified from the sera of inoculated pigs by PCR using primers TTV2-
tagF (5=-TGACACAGGA/CGTAGGAAATGCAGT-3=) and TTV2-tagR
(5=-TGAAGTATTTAGGGTCATTTGTAGCA-3=) from selected serum
samples of pigs with viremia. The PCR products were gel purified and
cloned into a pCR2.1 vector by the TA cloning strategy. The white bacte-
rial clones on the 5-bromo-4-chloro-3-indolyl--D-galactopyranoside
(X-Gal)-containing agar plates were picked up for subsequent DNA ex-
traction and sequencing.
RESULTS
Neither the viral DNA nor the expression of the putative ORF1
capsidproteinofTTSuV1orTTSuV2was endogenouslypresent
in the five representative cell lines tested in this study.The pres-
ent study first aimed to identify potential permissive cell lines
supporting TTSuV propagation.We selected five commonly used
cell lines, including three that are of pig origin: PCV1-free PK-15,
3D4/31, and IPEC-J2 and two other cell lines, BHK-21 and
MARC-145. These cell lines are known to be permissive to a wide
variety of animal virus infections. In order to rule out the possi-
bility of endogenous contamination of cultured cell lines with
TTSuV1 or TTSuV2, the expression of both viral DNA and ORF1
protein was subjected to TTSuV1 or TTSuV2 real-time qPCR and
IFA detection, respectively. OIE disease-free porcine serum that
had been shown to have a high level of anti-TTSuV2 ORF1 anti-
body was also included as a control (15). The results of the qPCR
analysis showed that none of the five cell lines tested in this study
were positive for TTSuV1 or TTSuV2 DNA, as determined by the
analyses of fluorescence curves, melting curves, and agarose gel
electrophoresis, since their fluorescence curves were below the
minimum detection limit, their melting curves did not overlap
those of the standards, and there were no specific bands corre-
sponding to the expected PCR products (Fig. 2). The bands from
the cell samples close in size to the standardswere excised from the
gel, sequenced, and found to be porcine andmammalian genomic
sequences. The swine-derived trypsin and FBS products used for
cell cultures were also negative (data not shown). In contrast, as
expected, the commercial porcine serumwas positive for TTSuV1
and TTSuV2 DNA (Fig. 2).
To develop cell-based serological methods such as IFA or im-
munoperoxidase monolayer assay for TTSuV detection, we raised
three specific antisera against the putative ORF1 capsid protein of
TTSuV1a, TTSuV1b (Huang et al., submitted), or TTSuV2 in rab-
bits. When the five cell lines were stained with each of the three
virus-specific antisera, respectively, no positive fluorescence sig-
nals were detected, indicating the absence of endogenous TTSuV1
or TTSuV2 ORF1 expression (data not shown). The IFA results
were consistent with the qPCR detection, which demonstrated
that the five selected cell lines were not contaminated with
TTSuV1 or TTSuV2 and thus can be used to test for susceptibility
to TTSuV infection or replication by transfection with TTSuV2
DNA clones.
Construction and characterization of full-length TTSuV2
genomic DNA clones in porcine kidney PK-15 cells. We were
particularly interested in characterizing the infectivity of the
TTSuV2 full-length DNA clone, since TTSuV2 has been reported
to be associatedwith PMWSor PCVADat a high rate of viral DNA
prevalence (20), a large viral load (1), and a low antibody level in
disease-affected pigs with an unknown mechanism (15). We first
generated twomonomeric full-length TTSuV2DNA clones, pSC-
PTTV2c and pSC-TTV2-#471942, derived from prototype U.S.
isolate PTTV2c-VA and German isolate TTV2-#471942, respec-
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tively (Fig. 1A and C) (9, 16). Each full-length TTSuV2 genomic
DNA was inserted into cloning vector pSC-B-amp/kan, which
does not contain a eukaryotic promoter. BamHI or EcoRV is the
unique restriction site in the PTTV2c-VA or TTV2-#471942 ge-
nome, which was engineered at both ends of the genomic DNA to
facilitate the generation of concatemers and thus to mimic the
TTSuV circular DNA genome. Single digestion of the plasmid DNA
of each clone with BamHI or EcoRV resulted in two different frag-
ments of 4.3 kb and 2.8 kb. The 4.3-kb fragment represented the
backbone vector, whereas the 2.8-kb fragment represented the in-
sertedmonomeric TTSuV2 genomic DNA (data not shown).
Subsequently, two copies of the full-length PTTV2c-VA ge-
nome from clone pSC-PTTV2c were ligated in tandem into the
pSC-B-amp/kan vector to generate clone pSC-2PTTV2c-RR (Fig.
1B). Comparison of the AflII single-digestion patterns of pSC-
PTTV2c and pSC-2PTTV2c-RR showed that the latter clone had
an additional 2.8-kb fragment representing the intact single
TTSuV2 genomic DNA (Fig. 3A, right side). We utilized the same
cloning strategy to produce a tandem-dimerized TTSuV2 DNA
clone, pSC-2PTTV2b-RR, derived frompSC-TTV2-#471942 (Fig.
1D). The construct pSC-TTV2-#4719421 has two HindIII sites;
one is located in the TTSuV2 genome, and the other is located in
the vector. The short distance between them is 2.1 kb. When di-
gested with HindIII alone, the construct pSC-TTV2-#4719421
produced two fragments of 2.1 and 4.9 kb, whereas the construct
pSC-2PTTV2b-RR gave an additional 2.8-kb fragment represent-
ing the intact single TTSuV2 genome (Fig. 3A, left side), thus
confirming the successful construction of the clone.
FIG 2 Detection of TTSuV1 or TTSuV2 contamination in five different cell lines (PCV1-free PK-15, 3D4/31, IPEC/J2, BHK-21, and MARC-145) and an OIE
disease-free porcine serum by real-time qPCR. Fluorescence curves (A and C) and melting curves (B and D) of TTSuV1 (A and B) or TTSuV2 (C and D) qPCR
products are shown after 40 cycles of amplification of the standard template with the minimum dilution limit (104 pg; indicated by red), five different cell lines
(blue) and the porcine serum (green). For each sample, duplicate determinations were made. (E) Detection of specific TTSuV1 or TTSuV2 qPCR products
(marked by black arrowheads) by agarose gel electrophoresis.
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Circular TTSuV2 DNA was generated by tandem ligation of
the purified linear TTSuV2 genomic DNA excised from clone
pSC-PTTV2c or pSC-TTV2-#471942. Typical monomer, dimer,
and high-copy-number molecules of concatemerized TTSuV2
DNA were observed in the ligation products (Fig. 3B). The liga-
tionmixture fromPTTV2c-VA or TTV2-#471942was transfected
into PCV1-free PK-15 cells. IFA conducted at 5 days posttransfec-
tion using rabbit antiserum against PTTV2c-VA ORF1 indicated
that the TTSuV2 ORF1 antigen was expressed in the nuclei of the
transfected cells with an approximately 5% positivity rate (Fig. 4A
and C). No fluorescent signal was observed in mock-transfected
cells stained with the same anti-TTSuV2 serum (Fig. 4E) or in
circular TTSuV2 DNA-transfected cells stained with the anti-
TTSuV1a ORF1, anti-TTSuV1b ORF1 (Huang et al., submitted),
or prebleed rabbit serum (data not shown). Passage of the trans-
fected cells two times did not eliminate but did reduce the fluo-
rescent signal (data not shown). When the transfected cells were
continuously passaged for up to 20 passages, no positive signal was
detectable, suggesting that TTSuV2 infection did not occur (data
not shown).
We next tested whether direct transfection of plasmid DNA of
tandem-dimerized clone pSC-2PTTV2c-RR or pSC-2PTTV2b-RR
into PK-15 cells resulted in the synthesis of TTSuV2 ORF1. A trans-
fection efficiency of 50 to 60% in PK-15 cells was measured by using
a green fluorescent protein (GFP) expression construct with the
Lipofectamine LTX reagent (data not shown). The tandem-dimerized
double-strandedDNAdoes not represent genomic anellovirus DNA
but might represent an infectious replicative intermediate. IFA at 5
days posttransfection using the same anti-TTSuV2 ORF1 antiserum
confirmed that bothDNA clones also expressedORF1 in transfected
PK-15 cells (Fig. 4B andD).Again,ORF1was expressed in cell nuclei.
However, the fluorescence intensity and positivity rate were lower
than those incircularTTSuV2DNA-transfectedcells (Fig. 4BandD).
Wedidnotobserve localizationof theORF1antigen in the cytoplasm
of the transfected cells.
Experimental identification of two introns in the TTSuV2
genome. Although the transcriptional profile of cloned TTSuV
full-length genomic DNA has not been reported, we previously
speculated that TTSuV likely expresses two essential viral mRNA
transcripts, mRNA1 and mRNA2, to produce the four known
FIG 3 Identification and quality assessment of linear or circular TTSuV2 genomic DNA. (A) Comparisons of the HindIII single-digestion patterns between
clones pSC-TTV2-#471942 and pSC-2PTTV2b-RR (left side) and AflII single-digestion patterns between clones pSC-PTTV2c and pSC-2PTTV2c-RR (right
side) by agarose gel electrophoresis. Lanes M, DNAmarkers. The results were consistent with the predicted patterns of the digested fragments (shown by black
arrowheads). The 2.8-kb fragments indicate the intact single TTSuV2 genomic DNA from clone pSC-2PTTV2b-RR or pSC-2PTTV2c-RR. (B) Quality assess-
ment of concatemerized ligation products of the BamHI-digested and purified PTTV2c genomic DNA. Samples were electrophoresed in a 1% agarose gel before
(linear DNA) and after (ligation mixture) T4 DNA ligase treatment. Linear DNA (2.8 kb) and the putative one-copy (monomer), two-copy (dimer), and
high-copy-number circular DNAs formed are indicated by arrowheads.
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FIG 4 IFA results of PCV1-free PK-15 cells transfected with the ligation mixtures of linear TTSuV2 genomic DNA derived from clone pSC-PTTV2c (A) or
pSC-TTV2-#471942 (C) with plasmid pSC-2PTTV2c-RR (B) or pSC-2PTTV2b-RR (D) or with Lipofectamine LTX only (E). Cells were stained with a rabbit
anti-TTSuV2 ORF1 polyclonal antibody and Texas Red-conjugated goat anti-rabbit IgG (red) at 5 days posttransfection (left column). DAPI (blue) was used to
stain the cell nuclei (middle column). The antibody and DAPI stainings are shown merged in the right column. Magnification,200.
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ORF counterparts of human TTV (Fig. 5A) (16). Continuous
mRNA1 encodes ORF1 and ORF2, whereas removal of the puta-
tive intron of 1,341 nucleotides (nt) (designated intron 1 here),
corresponding to nucleotide positions 648 to 1988 in the
PTTV2c-VA genome, generates putativemRNA2, which contains
two discontinuousORFs,ORF1/1 andORF2/2 (16).We also spec-
ulated that more spliced mRNAs and their encoded proteins of
TTSuV may exist, as shown for human TTV (30, 38).
To determine whether the splicing of putative intron 1 in
TTSuV2 occurred, total RNA was extracted from PK-15 cells
transfected with circular PTTV2c-VA DNA, followed by DNase I
treatment and RT-PCR analysis. Two PCR product bands of ap-
proximately 500 bp and 600 bp were visualized by agarose gel
electrophoresis. Sequencing of the cloned PCR fragments resulted
in the identification of two sequences. As expected, the large
cDNA fragment of 583 bpwas exactly the intron 1-spliced product
FIG5 Putative transcription profile and protein expression of TTSuV2 based on the PTTV2c-VA genome. (A) Schematic diagramof three putative viralmRNAs
and six viral proteins. The TATA box, splicing sites (SD, splicing donor; SA, splicing acceptor), and positions of primers TTV2-448F and TTV2-2316R are
indicated at the top. The three ORFs are depicted as boxes. The sizes of the six ORFs and two introns are also shown. aa, amino acids. (B) Sequencing of the
RT-PCR products amplified by primers TTV2-448F and TTV2-2316R verified the splicing of putative intron 1. The actual viral mRNA2 is illustrated, and the
nucleotide positions of both ends of mRNA2 and the splicing sites are marked. (C) Sequencing of the RT-PCR products amplified by primers TTV2-448F and
TTV2-2316R identified an additional intron (intron 2). The actual viral mRNA3 is illustrated, and the nucleotide positions of both ends of mRNA3 and the
splicing sites are marked. Arrows and numbers indicate the joint sites of the exons.
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(Fig. 5B), whereas the small cDNA product of 492 bp contained
two splicing regions, including intron 1 and an additional 91-nt
intron, corresponding to nucleotide positions 2103 to 2193 in the
PTTV2c-VA genome, which was designated intron 2 in this study
(Fig. 5C). The splicing sites are conserved among all of the pub-
lished TTSuV2 sequences (data not shown). Therefore, in this
study, for the first time, we experimentally demonstrated the ex-
istence of splicing of intron 1 and the viralmRNA2 transcripts.We
also identified a novel viral mRNA transcript, termed mRNA3,
which encodes two putative proteins, ORF1/1/2 and ORF2/2/3,
and which switches reading frames from 1 to 2 and 2 to 3, respec-
tively, due to the splicing of intron 2 (Fig. 5A). The mRNA3 tran-
script contains at least three exons in the TTSuV2 genome. Since
we failed to determine the 5= and 3= ends of the viral mRNA tran-
scripts by rapid amplification of cDNA ends-PCR, it is possible
that there exists an additional TTSuV2 intron in the region up-
stream of ORF2, as known in human TTV transcripts (30). How-
ever, the human TTV genome does not contain a short intron
corresponding to TTSuV intron 2 in the region downstreamof the
large intron (intron 1).
Nevertheless, transfection of PK-15 cells with circularized
TTSuV2 genomic DNA resulted in the synthesis of viral mRNA
transcripts and expression of theORF1protein, indicating that the
TTSuV2 concatemers likely mimicked the transcription of and
protein expression from the natural circular genome of TTSuV2.
A tandem-dimerized TTSuV2 clone, pSC-2PTTV2c-RR, is
infectiouswhen inoculated intoCDpigs.To test the infectivity of
TTSuV2DNA clones in pigs, we first performed a pilot study with
three groups of CD pigs with two pigs per group. The pigs were
inoculated with PBS buffer (pigs 1 and 2) in group 1, the tandem-
dimerized clone pSC-2TTV2c-RR (pigs 3 and 4) in group 2, and
pSC-2TTV2b-RR (pigs 5 and 6) in group 3, respectively. Serum
samples were collected from the animals at 0, 7, 14, 21, 28, 35, and
42 dpi. Pig no. 2 died of septicemia due to an unidentified bacterial
infection shortly after inoculation.
TTSuV2DNAwas detected by real-time qPCR beginning at 28
dpi in two pigs inoculated with pSC-2TTV2c-RR. The viral loads
of both pigs, although very light, increased weekly until 42 dpi
before necropsy at 44 dpi. The viral load in the serum of pig no. 3
increased from 1.93 103 copies/ml at 28 dpi to 5.59 103 cop-
ies/ml at 35 dpi and 4.36  104 copies/ml at 42 dpi, whereas the
serum viral loads in pig no. 4 rose from 5.07 103 copies/ml at 28
dpi to 4.49 104 copies/ml at 35 dpi and 8.87 104 copies/ml at
42 dpi. Moderate microscopic lesions in the brain (lymphoplas-
macytic encephalitis, mainly perivascular), liver (lymphohistio-
cytic hepatitis), and kidney (lymphoplasmacytic interstitial ne-
phritis) were observed in pig 3 but not in pig 4. The remaining
three pigs, including pigs inoculatedwith clone pSC-2TTV2b-RR,
did not develop viremia during this study. However, pig no. 5 had
mild lymphohistiocytic multifocal hepatitis. The results of this
pilot pig experiment indicated that clone pSC-2PTTV2c-RR,
from a U.S. strain of TTSuV2, is infectious.
Characterization of two TTSuV2 full-length genomic DNA
clones with engineered genetic markers and a derived mutant
clone in vitro. To further rule out possible contamination with
other indigenous TTSuV2 strains in the pilot animal study, it is
critical to introduce tractable genetic markers into the TTSuV2
genome so that the cloned virus and the potential indigenous con-
taminating virus in pigs can be discriminated in inoculated ani-
mals. We introduced a unique HpaI restriction site and two
unique restriction sites, PstI and MfeI, into two TTSuV2 mono-
meric DNA clones, pSC-TTV2-#471942 and pSC-PTTV2c, to
produce two new clones, pSC-TTV2-EU and pSC-TTV2-US, re-
spectively (Fig. 1E and F). The positions of these sites, located in
intron 1, were expected not to change the putative ORF1 capsid
amino acid sequence. PK-15 cells were transfected with ligation
mixtures of the linear TTSuV2 genomic DNA excised from these
two marker clones, respectively. ORF1 expression in the nuclei of
transfected cells was detected by IFA at 3 days posttransfection,
similar to the patterns of their parental clones (Fig. 6), indicating
that the clones with introduced genetic markers were replication
competent.
Mutant clone pSC-TTV2-AA, with a 104-bp deletion (nucle-
otide positions 332 to 437) from the putative TATA box (nucleo-
tide positions 283 to 289; Fig. 5A) to the ORF1 (nt 528) andORF2
(nt 445) start codons, was generated based on clone pSC-
TTV2-US (Fig. 1G). When transfected into the PK-15 cells, the
circularized DNA from this mutant clone did not express the
ORF1 antigen (Fig. 6), suggesting that the deleted region likely
contains a cis-acting element important for viralmRNA transcrip-
tion or TTSuV2 ORF1 translation. The result obtained with the
deletionmutant clone also implied that the observed expression of
ORF1 is likely driven by replication-competent TTSuV2 DNA
since the tandem-dimerized clone and concatemerized ligation
FIG 6 IFA results of PCV1-free PK-15 cells transfected with the ligation mixtures of linear TTSuV2 genomic DNA derived from clone pSC-TTV2-EU,
pSC-TTV2-US, or pSC-TTV2-AA. Cells were stained with an anti-TTSuV2 ORF1 antibody and Alexa Fluor 488-conjugated goat anti-rabbit IgG (green) at 3
days posttransfection. DAPI (blue) was used to stain the cell nuclei. Only merged images of antibody and DAPI stainings are shown. Magnification,200.
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products from the parental PTTV2c-VA genome were both infec-
tious in pigs (see below).
Expression of the TTSuV2ORF1 protein in various cell lines
transfectedwith the circularizedTTSuV2DNA fromclonepSC-
TTV2-US. From the in vitro transfection experiments described
above, it appeared that although the TTSuV2 putative ORF1 cap-
sid protein is expressed, the PK-15 cells do not support the cell-
to-cell spread of TTSuV2 recovered from the introduced TTSuV2
DNA clones. Alternatively, it is possible that the assembly of
TTSuV2 virions in the transfected PK-15 cells is deficient. To
search for another cell line that may be permissive for TTSuV2
infection, we subsequently transfected 11 other different cell lines
with the circularized TTSuV2 DNA from clone pSC-TTV2-US,
respectively. These cell lines included the four cell lines (3D4/31,
IPEC-J2, BHK-21, and MARC-145) that were negative for
TTSuV1 or TTSuV2 at both the DNA and protein levels. Plain
cells of the other seven lines (ST, Vero, 293TT, HeLa, Huh-7,
HepG2, and CHO-K1) were also negative for TTSuV2 ORF1, as
determined by IFA (data not shown).
After transfection, all of the 11 cell lines expressed the ORF1
protein at 3 days posttransfection (Fig. 7; BHK-21 and CHO-K1
results not shown). The percentages of transfected cells with positive
IFA signals were subjectively categorized into the following three lev-
els: IPEC-J2, ST, PCV1-free PK-15, Huh-7, and HepG2 with a high
positivity rate (5%); 3D4/31, Vero, MARC-145, and 293TT with a
medium positivity rate (2 to 5%); andHeLa, BHK-21, and CHO-K1
with a low positivity rate (2%). In general, TTSuV2-specific anti-
body staining patterns of individual positive cells by IFA could be
divided into three different types: (i) cells displaying dense nuclear
staining; (ii) cells displaying large nuclear inclusion staining; and (iii)
cells displaying punctate nuclear staining. The last two patterns indi-
cated the localization of ORF1 antigen in cell nucleoli. No cytoplas-
mic staining was observed in transfected cells.
To test if some of these IFA-positive cells were susceptible to
TTSuV2 infection, supernatants collected from lysates of PK-15,
ST, and 293TT cells transfected with circularized TTSuV2 DNA
were inoculated into all of the cell lines with a high rate of positiv-
ity and some with a medium rate of positivity, including the
293TT cell line, respectively. The inoculated cells were cultured for
3 to 5 days and examined by IFA. No fluorescent signal was de-
tected in these cells (data not shown), indicating that none of the
cell lines tested are susceptible to TTSuV2 infection.
Rescue of TTSuV2 from concatemerized TTSuV2 genomic
DNA of clone pSC-TTV2-US in CD/CD pigs. With the intro-
FIG 7 Transfection of nine different cell lines with the ligation mixture of linear TTSuV2 genomic DNA derived from clone pSC-TTV2-US. Images of Alexa
Fluor 488-conjugated antibody staining (green) merged with nuclear staining with DAPI (blue) are shown. Magnification,200.
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duced genetic markers in the full-length DNA clones that can be
used to distinguish between infections caused by the cloned virus
and potential indigenous contaminating virus, we performed an ad-
ditional studywithCD/CDpigs to further verify the in vivo infectivity
of the TTSuV2 genomic DNA clones. Twelve CD/CD pigs were as-
signed to three groups of four pigs each. Pigs in each group were
inoculated with PBS buffer, concatemerized TTV2-EU DNA, and
TTV2-USDNA, respectively. Preinoculation serum samples fromall
of the pigs (collected 30 days prior to inoculation) were negative for
TTSuV1 or TTSuV2 DNA by real-time qPCR. Serum samples were
collected from all of the animals at 0, 7, 14, 21, 28, and 35 dpi.
TTSuV2 DNA was detected in all eight inoculated pigs, but
unfortunately, it was also detected in two negative-control pigs
(no. 136 and 142), indicating contamination with other strains of
TTSuV2 indigenous in the research facility or the source pigs,
which is not uncommon (see Table S1 in the supplemental mate-
rial). One pig (no. 133) inoculated with the concatemerized
TTSuV2-US DNA had detectable viremia even at 0 dpi, whereas
the other pigs developed viremia at 14 or 21 dpi (see Table S1 in
the supplemental material). Except for pig no. 133, the seven
TTSuV2 DNA-inoculated pigs and the two TTSuV2-positive pigs
in the negative-control group had increased viral loads until nec-
ropsy, indicating active virus infection (see Table S1 in the supple-
mental material). We speculated that the source of the TTSuV2
contamination was likely due to the 1-month waiting period be-
tween the date of preinoculation serum sample testing (by which
all of the animals were negative) and 0 dpi. Since total DNA was
extracted from these samples without DNase I pretreatment, to
rule out the possibility of the presence of inoculated free DNA in
the sera from pig no. 133, serum samples from this pig and from
pigs no. 136 and 142 in the negative-control group with positive
PCR results were subjected to DNase I treatment or left treated
before DNA extraction followed by qPCR. The result was consis-
tent with Table S1 in the supplemental material, showing that
there was no significant viral load difference between DNase I-
treated and untreated samples (see Table S2 in the supplemental
material).
However, thanks to the introduced genetic markers in the
TTSuV2 DNA clones used in this study, we were still able to de-
termine if the TTSuV2 DNA clones were infectious in pigs, which
was the main objective of our study. Since we have previously
demonstrated that a single pig can be infected with multiple
strains of TTSuV2 and TTSuV1 (9, 16), prior infection or concur-
rent infection with an indigenous TTSuV2 strain should not in-
terfere with the infection of pigs with the TTSuV2 DNA clones we
intended to test in this study. To determine if the genetic markers
of TTSuV2-EU or TTSuV2-US were present in viruses recovered
from the sera of infected pigs with the mixed TTSuV2 infection
status, we amplified and sequenced a 620-bp region containing the
engineered genetic markers from selected samples at 35 dpi from
both inoculated and negative-control pigs. The results showed
that only the serum samples from pigs experimentally inoculated
with the concatemerized TTSuV2-US DNA had TTSuV2 se-
quences identical to the introduced geneticmarkers PstI andMfeI,
whereas serum samples from the negative-control group and from
pigs inoculatedwith concatemerized TTV2-EUDNAdid not con-
tain any introduced genetic markers (data not shown). Therefore,
this pig study further confirmed the initial pilot pig study inwhich
the TTSuV2-US full-lengthDNA clone was infectious in pigs. The
results also experimentally verified, for the first time, that pigs can
be coinfected with different strains of TTSuV2.
DISCUSSION
Little is known about the biology and pathogenicity of anellovi-
ruses due to the lack of a cell culture system to propagate human
TTV or TTSuV and the lack of a suitable animal model combined
with reverse genetic systems for anellovirus studies. Reports of
TTSuV DNA sequences detected in commercial porcine vaccine
products, in swine-derived human drugs, and in swine-derived
trypsin by nested PCR suggested widespread contamination with
TTSuV (19, 22). Cell cultures may be one of the major sources of
TTSuV contamination in biological products of pig origin. There-
fore, the present study was first aimed at examining whether five
selected cell lines harbor endogenous DNA and protein antigen of
TTSuV1 or TTSuV2 and to further identify TTSuV-negative cell
lines that are potentially permissive of TTSuV propagation.
Surprisingly, none of the five cell lines tested in this study were
found to be positive for TTSuV1 or TTSuV2 DNA or ORF1 anti-
gen (Fig. 2). Furthermore, screening of seven additional com-
monly used cell lines also yielded negative results, as determined
by IFA detection (data not shown), indicating that TTSuV con-
tamination in cell cultures is probably not as common as we orig-
inally thought. Our result was distinct from that of a recent study
by a Brazilian group that reported TTSuVDNA contamination in
15 of 25 cell lines (41). In that study, the five cell lines that were
also used in our study, i.e., PK-15, ST, BHK-21,Vero, andMA-104
cells (from which the MARC-145 cell line is derived) were shown
to have detectable TTSuV1 and/or TTSuV2 sequences by the use
of a one-round duplex PCR assay (41). It is unclear why there is
such a major discrepancy between the results of our study and
those obtained by the Brazilian group. A reliable approach to
proving the presence of a contaminating virus in cell cultures used
in biological products is to determine the cells’ susceptibility to
virus infection, which has been exemplified by PCV1 (2, 12, 25,
42). Theoretically, the possibility of TTSuV contamination in cell
cultures is very low, since anellovirus has been shown to be ex-
tremely difficult to propagate in vitro. The present study utilized
the (i) more sensitive qPCR assay (compared to the one-round
PCRused byTeixeira et al. [41]); (ii) the IFA; and (iii) transfection
of circular TTSuV genomic DNA into the cells as the positive
control (see below) to demonstrate the absence of TTSuV at both
the DNA and amino acid levels in 12 representative cell lines,
including four of pig origin (PK-15, ST, 3D4/31, and IPEC-J2).
Therefore, based on the results of this study, we conclude that,
contrary to what some may believe, there is very little, if any,
endogenous TTSuV contamination in well-established continu-
ous cell lineages. Instead, the detection of contaminating TTSuV
DNA sequences in biological products reported by other groups
may be due to the swine-derived trypsin (19, 41) or serum prod-
ucts used. The former was not detected (data not shown), but the
latter was actually confirmed in the present study for the first time
(Fig. 2).
Subsequently, we demonstrated that all of these TTSuV-free
cell lines supported TTSuV2 ORF1 expression by transfection
with circular TTSuV2 genomic DNA or tandem-dimerized
TTSuV2 plasmids (Fig. 4, 6, and 7). The TTSuV2 ORF1 protein
was expressed in cell nuclei, especially in nucleoli, which is con-
sistent with the localization of human TTV ORF1 in Huh-7 cells
transfected with the circular full-length TTV genomic DNA by
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immunoblotting with the ORF1-specific antibody (30). Most re-
cently, it was also reported that TTSuV1 or TTSuV2 ORF1-GFP
fusion protein expressed from the recombinant construct accu-
mulated in the nucleoli of PK-15 cells (27).
In addition, in this study TTSuV2-specific mRNA splicing
events were detected in transfected PK-15 cells by RT-PCR, indi-
cating the synthesis of viral mRNA transcripts in the transfected
cells. While we experimentally demonstrated the existence of two
viral mRNA transcripts (mRNA2 and mRNA3) (Fig. 5), putative
mRNA1, encoding full-length ORF1 of TTSuV2, was not detected
(data not shown), whichmay suggest a smaller quantity and lower
integrity of mRNA1 than of mRNA2 and mRNA3. In accordance
with the result described by Martinez-Guinó et al., splicing of the
91-nt intron 2 sequence intomRNA3 also occurred posttranscrip-
tion of the TTSuV2 ORF1-GFP fusion gene based on a non-full-
length viral clone (27).
The synthesis of viral mRNA transcripts and the subsequent
expression of ORF1 or ORF1-related viral protein in transfected
cells were driven by the endogenous TTSuV2 promoter. The pro-
cesses were also regulated by the unidentified cis-acting elements,
as we showed in this study that deletion of a 104-bp sequence
downstream of the TATA box completely eliminated ORF1 ex-
pression (Fig. 6). To our knowledge, this is the first demonstration
of porcine anellovirus mRNA and protein expression and mu-
tagenesis analysis based on the viral DNA concatemers produced
from circularized viral genomes or a tandem-dimerized full-
length clone.
It appeared that both the PTTV2c-VA and TTV2-#471942
DNA concatemers were replication competent when transfected
into cells since they mimicked the natural TTSuV2 circular ge-
nome. However, the rescue of PTTV2c-VA (TTV2-US) but not
TTV2-#471942 (TTV2-EU) was demonstrated in only two in vivo
animal experiments. Themajor sequence difference between these
two TTSuV2 strains was in the GC-rich region. It has been pro-
posed that theGC-rich region in anelloviruses formsunique stem-
loop structures that may play a significant role in viral replication
(29, 35). Further in-depth mutagenesis analysis, which was be-
yond the scope of the present study, is required to explain this
discrepancy between the two clones.
We also showed that although the three cell lines tested in this
study (PK-15, ST, and 293TT) supported a limited level of
TTSuV2 replication, the infection of these cells with TTSuV2, if
any, was nonproductive since the supernatants of the transfected
cells did not induce a second-round infection. Most recently, the
293TT cell line was shown to be susceptible to human TTV prop-
agation due to its expression of SV40 large T antigen at a high level
(5). The authors proposed that the human TTV genome contains
a conserved octanucleotide in theUTR forming a stem-loop as the
putative origin of replication. Five 4-bp motifs (CGGG and
GGGC) were found adjacent to the stem-loop that may act as the
recognition sites for the SV40 large T antigen to facilitate TTV
replication (5). However, when we performed a sequence align-
ment analysis of the corresponding sequences among human
TTV, TTSuV, torque teno canis virus (dog anellovirus), and
torque teno felis virus (cat anellovirus), neither the conserved oc-
tanucleotide nor the 4-bp motif was identified in the latter three
anelloviruses (data not shown). Therefore, the SV40 large T pro-
tein expressed in 293TT cells likely does not have the proposed
helper effect on TTSuV replication. Further study is needed to
determine whether additional cell lines are permissive to TTSuV2
infection.
Previous studies by our group and others have demonstrated
that, even under strictly controlled experimental conditions in
research facilities, TTSuV-negative pigs can easily acquire TTSuV
infection due to the ubiquity of this virus in pigs and environ-
ments (10, 15). Although our second in vivo experiment in the
present study unfortunately “validated” these previous reports,
our results did demonstrate the successful rescue of TTSuV2 in
pigs inoculated with either the tandem-dimerized plasmids or cir-
cular TTSuV2 DNA with the introduced genetic markers. Unfor-
tunately, due to the presence of indigenousTTSuV2 in theCD/CD
pigs from the second animal study, we could not analyze or cor-
relate any pathological lesions in the inoculated pigs with TTSuV
infection. Therefore, a future study using germfree gnotobiotic
pigs and the infectious DNA clone is warranted to characterize the
pathological lesions attributable solely to TTSuV2 infection. In
addition, serum samples containing known loads of the rescued
TTSuV2-US strain can be used as virus stocks for experimental
infection of TTSuV2-negative pigs in future studies. The availabil-
ity of the pig model combined with the anellovirus reverse genetic
system described in this report will facilitate future studies of por-
cine and even human anellovirus biology and pathogenesis.
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